Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
50.9±25.0 µM
Hemolytic
Cytotoxic
50% Hemolysis | 50.9±25.0 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria. | Biochim Biophys Acta | 2013